InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the complete record of transactions filed by McNeill Jonathan, Dirigeant. Director active across 1 companies, notably Dyne Therapeutics, Inc.. Aggregated, 6 disclosures have been recorded. Total volume traded: €18k. The latest transaction was disclosed on 14 June 2022 — Disposition. Regulator: SEC (Form 4). The full history is free.
Declarations6 total
€2,390504 shares@ €4.74110.0001% mcap11.5% of flow
Common Stock
SEC:0001209191-22-037150:0·
€3,813481 shares@ €7.92630.0001% mcap18.4% of flow
Common Stock
SEC:0001209191-22-018536:0·
025,311 shares0
Common Stock
SEC:0001209191-21-069425·
025,311 shares0
Common Stock
SEC:0001209191-21-069425:0·
€7,253545 shares@ €13.30750.0003% mcap100.0% of flow
Common Stock
SEC:0001209191-21-057325·
€7,253545 shares@ €13.30750.0003% mcap35.0% of flow
Common Stock
SEC:0001209191-21-057325:0·
6 of 6 declarations
About McNeill Jonathan
Jonathan McNeill is an Executive at Dyne Therapeutics, Inc. He is involved in managing the company's operations and strategy, aiming to strengthen its position in the biopharmaceutical market.
